483 Satya Deeptha Pharmaceuticals Jan 2018

483 Satya Deeptha Pharmaceuticals Jan 2018

Cheryl Clausen FDA$119.00 - Available Now

FDA investigators audited the Satya Deeptha Pharmaceuticals - Humnabad, India facility and issued inspectional observations (via FDA 483) on 11 Jan 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 11 Jan 2018
  • Location: Humnabad, India
  • FEI: 3013987923
Add To Cart